Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

NCT00304447 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myelocytic, Acute
Infusions, Intravenous

Interventions

DRUG: Mylotarg

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer